Nephros Stock Price, News & Analysis (OTCMKTS:NEPH)

$0.48 0.02 (4.37 %)
(As of 01/16/2018 10:38 AM ET)
Previous Close$0.48
Today's Range$0.48 - $0.48
52-Week Range$0.18 - $0.60
Volume334 shs
Average Volume28,224 shs
Market Capitalization$24.99 million
P/E Ratio-11.94
Dividend YieldN/A
Beta-0.46

About Nephros (OTCMKTS:NEPH)

Nephros, Inc. (Nephros) is a commercial-stage medical device and commercial products company that develops and sells high performance liquid purification filters and hemodiafiltration (HDF) systems. The Company's filters, ultrafilters, are primarily used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate, and used in hospitals for the prevention of infection from water borne pathogens, such as legionella and pseudomonas. The Company has approximately two product lines: HDF Systems and Ultrafiltration Products. Its products in HDF modality deliver therapy for End Stage Renal Disease (ESRD) patients. It offers ultrafilters for customers in hospitals and other healthcare facilities for filtration of water to be used for patient washing and drinking as an aid in infection control. The filters also produce water that is suitable for wound cleansing, cleaning of equipment used in medical procedures and washing of surgeons' hands.

Receive NEPH News and Ratings via Email

Sign-up to receive the latest news and ratings for NEPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:NEPH
CUSIPN/A
Phone201-343-5202

Debt

Debt-to-Equity Ratio3.54%
Current Ratio1.13%
Quick Ratio0.72%

Price-To-Earnings

Trailing P/E Ratio-11.9375
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.32 million
Price / Sales11.18
Cash FlowN/A
Price / CashN/A
Book Value$0.01 per share
Price / Book47.75

Profitability

Trailing EPS($0.04)
Net Income$-3,030,000.00
Net Margins-84.60%
Return on Equity-358.70%
Return on Assets-94.93%

Miscellaneous

Employees10
Outstanding Shares54,330,000

Nephros (OTCMKTS:NEPH) Frequently Asked Questions

What is Nephros' stock symbol?

Nephros trades on the OTCMKTS under the ticker symbol "NEPH."

How were Nephros' earnings last quarter?

Nephros, Inc. (OTCMKTS:NEPH) released its quarterly earnings results on Thursday, November, 9th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $0.92 million for the quarter. Nephros had a negative return on equity of 358.70% and a negative net margin of 84.60%. View Nephros' Earnings History.

When will Nephros make its next earnings announcement?

Nephros is scheduled to release their next quarterly earnings announcement on Monday, March, 19th 2018. View Earnings Estimates for Nephros.

Who are some of Nephros' key competitors?

Who are Nephros' key executives?

Nephros' management team includes the folowing people:

  • Daron Evans, President, Chief Executive Officer (Age 41)
  • Andrew Astor, Chief Financial Officer (Age 60)
  • Paul A. Mieyal Ph.D., Director (Age 46)
  • Malcom C. Persen, Director (Age 61)
  • Moshe Pinto, Director
  • Arthur H. Amron, Independent Director (Age 59)

How do I buy Nephros stock?

Shares of Nephros can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nephros' stock price today?

One share of Nephros stock can currently be purchased for approximately $0.48.

How big of a company is Nephros?

Nephros has a market capitalization of $24.99 million and generates $2.32 million in revenue each year. The company earns $-3,030,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. Nephros employs 10 workers across the globe.

How can I contact Nephros?

Nephros' mailing address is 41 GRAND AVENUE, RIVER EDGE NJ, 07661. The company can be reached via phone at 201-343-5202.


MarketBeat Community Rating for Nephros (NEPH)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  19 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  52
MarketBeat's community ratings are surveys of what our community members think about Nephros and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Nephros (OTCMKTS:NEPH) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Nephros (OTCMKTS:NEPH) Earnings History and Estimates Chart

Earnings by Quarter for Nephros (OTCMKTS:NEPH)

Nephros (OTCMKTS NEPH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/19/2018        
11/9/2017Q3 2017($0.01)$0.92 millionViewN/AView Earnings Details
8/8/2017Q2 2017($0.01)$0.86 millionViewN/AView Earnings Details
5/9/2017Q1 2017($0.01)$0.73 millionViewN/AView Earnings Details
3/20/2017Q4 2016($0.01)ViewN/AView Earnings Details
8/8/2016Q3 2016($0.01)$0.51 millionViewN/AView Earnings Details
5/11/2016Q1 2016($0.02)ViewN/AView Earnings Details
3/30/2016Q4 2015($0.02)ViewN/AView Earnings Details
11/10/2015Q3 2015($0.02)ViewN/AView Earnings Details
8/10/2015Q2 2015($0.06)ViewN/AView Earnings Details
5/15/2015Q1 2015($0.02)ViewN/AView Earnings Details
4/15/2015Q4 2014($0.22)ViewN/AView Earnings Details
11/14/2014Q3 2014($0.03)ViewN/AView Earnings Details
8/14/2014Q2 2014($0.03)ViewN/AView Earnings Details
5/14/2014Q1 2014($0.04)ViewN/AView Earnings Details
3/28/2014Q4 2013($0.07)ViewN/AView Earnings Details
11/14/2013Q3 2013($0.03)ViewN/AView Earnings Details
8/13/2013Q2 2013($0.05)ViewN/AView Earnings Details
5/8/2013Q1 2013($0.10)ViewN/AView Earnings Details
3/4/2013Q4 2012($0.09)ViewN/AView Earnings Details
11/8/2012Q3 2012($0.07)ViewN/AView Earnings Details
8/14/2012Q2 2012($0.07)ViewN/AView Earnings Details
5/15/2012Q1 2012($0.05)ViewN/AView Earnings Details
3/22/2012Q4 2011($0.06)ViewN/AView Earnings Details
11/14/2011Q3 2011($0.04)ViewN/AView Earnings Details
8/15/2011Q2 2011($0.06)ViewN/AView Earnings Details
5/16/2011Q1 2011($0.17)ViewN/AView Earnings Details
3/29/2011Q4 2010($0.90)ViewN/AView Earnings Details
11/12/2010Q3 2010($0.20)ViewN/AView Earnings Details
8/16/2010Q2 2010($0.20)ViewN/AView Earnings Details
5/13/2010Q1 2010($0.20)ViewN/AView Earnings Details
4/2/2010Q4 2009($0.22)ViewN/AView Earnings Details
11/12/2009Q3 2009($0.20)ViewN/AView Earnings Details
8/14/2009Q2 2009($0.20)ViewN/AView Earnings Details
3/31/2008Q4 2007($17.00)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Nephros (OTCMKTS:NEPH) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.05 EPS

Dividends

Dividend History for Nephros (OTCMKTS:NEPH)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Nephros (OTCMKTS NEPH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.00%
Insider Trades by Quarter for Nephros (OTCMKTS:NEPH)

Nephros (OTCMKTS NEPH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/4/2017Andrew AstorCFOBuy18,333$0.50$9,166.50View SEC Filing  
9/6/2017Daron EvansInsiderBuy29,580$0.24$7,099.20View SEC Filing  
8/28/2017Andrew AstorCFOBuy10,000$0.27$2,700.00186,709View SEC Filing  
8/22/2017Daron EvansInsiderBuy4,000$0.25$1,000.00View SEC Filing  
8/11/2017Andrew AstorCFOBuy20,000$0.26$5,200.00186,666View SEC Filing  
8/11/2017Daron EvansInsiderBuy70,000$0.26$18,200.00View SEC Filing  
6/9/2017Daron EvansInsiderBuy21,461$0.26$5,579.86View SEC Filing  
5/19/2017Daron EvansInsiderBuy30,000$0.26$7,800.00View SEC Filing  
12/7/2016Daron EvansInsiderBuy4,069$0.32$1,302.08339,428View SEC Filing  
12/5/2016Daron EvansInsiderBuy10,620$0.34$3,610.80329,339View SEC Filing  
12/1/2016Daron EvansInsiderBuy41,530$0.32$13,289.60284,140View SEC Filing  
8/31/2015Daron EvansCEOBuy44,175$0.57$25,179.75169,759View SEC Filing  
8/20/2015Daron EvansCEOBuy51,500$0.53$27,295.00125,584View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Nephros (OTCMKTS NEPH) News Headlines

Source:
DateHeadline
Nephros Announces Preliminary Financial Results for Fourth Quarter 2017Nephros Announces Preliminary Financial Results for Fourth Quarter 2017
finance.yahoo.com - January 4 at 9:47 AM
Nephros Receives $1.8 Million in Cash from Sale of Tax CreditsNephros Receives $1.8 Million in Cash from Sale of Tax Credits
finance.yahoo.com - December 13 at 10:08 AM
Nephros CFO to Present at the 10th Annual LD Micro Main EventNephros CFO to Present at the 10th Annual LD Micro Main Event
finance.yahoo.com - December 4 at 9:50 AM
ValuEngine Downgrades Nephros (NEPH) to SellValuEngine Downgrades Nephros (NEPH) to Sell
www.americanbankingnews.com - December 3 at 12:40 AM
Nephros, Inc. :NEPH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017Nephros, Inc. :NEPH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 9:57 AM
Nephros Inc. (NEPH) Expected to Post FY2017 Earnings of ($0.05) Per ShareNephros Inc. (NEPH) Expected to Post FY2017 Earnings of ($0.05) Per Share
www.americanbankingnews.com - November 17 at 8:30 PM
SeeThruEquity Issues Update on Nephros, Inc. (NEPH)SeeThruEquity Issues Update on Nephros, Inc. (NEPH)
finance.yahoo.com - November 15 at 6:41 AM

SEC Filings

Nephros (OTCMKTS:NEPH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Nephros (OTCMKTS NEPH) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.